Cencora, Inc. (COR)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for COR is $364.08, 6.8% above the last close of $340.92 on Oct 16, 2026; targets range from $327.86 to $438.27. Rating consensus: Buy.
Snapshot
- P/E25.3x
- P/E vs sector-10.0%
- P/E vs own-19.0%
- Target upside+6.8%
- ConsensusBuy
- Market cap$65.06B
- FCF yield+6.2%
- Insiders-$4.69M
- Earnings in19d
- News0.00
Why it moved
Cencora, Inc. (COR) fell 0.1% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.4).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $340.92 · +7.6% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50↑ in ~6d
- RSI70
- Support-1.7%
- Resistance+2.3%
- Off 52w high-8.5%
- Off ATH-8.5%
- 52w range$340.92
- Bollingerupper half
- MACD3.48
- ATR+2.1%
- Volume1.6x
Analyst price targets
9 firms with a target in the last 12 months · last close $340.92 · as of Oct 16, 2026
Strong buy 4 · Buy 7 · Hold 4 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q3 FY2026: Revenue +5.1% year over year, free cash flow 2.9% of revenue, operating margin 1.3%.
| Q3 FY2026 | Jun 30, 2026 | $84.75B | 3.94 | $2.43B | 4.3% | 1.3% | 0.9% |
| Q2 FY2026 | Mar 31, 2026 | $78.36B | 8.40 | $1.17B | 4.2% | 1.7% | 2.1% |
| Q1 FY2026 | Dec 31, 2025 | $85.93B | 2.87 | -$2.42B | 3.3% | 1.2% | 0.7% |
| Q4 FY2025 | Sep 30, 2025 | $83.73B | -1.75 | $2.88B | 3.1% | 1.0% | -0.4% |
| Q3 FY2025 | Jun 30, 2025 | $80.66B | 3.52 | -$73.97M | 3.3% | 1.2% | 0.9% |
| Q2 FY2025 | Mar 31, 2025 | $75.45B | 3.68 | $3.22B | 3.5% | 1.3% | 1.0% |
| Q1 FY2025 | Dec 31, 2024 | $81.49B | 2.50 | -$2.82B | 2.8% | 1.0% | 0.6% |
| Q4 FY2024 | Sep 30, 2024 | $79.05B | 0.02 | $818M | 2.7% | 0.9% | 0.0% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 2 |  | $790.74 | -0.7% | -7.2% | +8.7% | 19.6 | $81.41B | |
| 3 |  | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 4 | | $340.92 | -0.1% | -8.5% | +6.8% | 25.3 | $65.06B | |
| 5 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 6 |  | $254.06 | +0.1% | 0.0% | +4.5% | 35.1 | $58.83B | |
| 7 |  | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 8 |  | $86.38 | -0.7% | -4.9% | +6.0% | 25.2 | $9.63B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.